Identification of AChE targeted therapeutic compounds for Alzheimer’s disease: an in-silico study with DFT integration
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Identification of AChE targeted therapeutic compounds for Alzheimer’s disease: an in-silico study with DFT integration ; volume:14 ; number:1 ; day:5 ; month:12 ; year:2024 ; pages:1-21 ; date:12.2024
Scientific reports ; 14, Heft 1 (5.12.2024), 1-21, 12.2024
- Urheber
-
Rawat, Kalpana
Tewari, Disha
Bisht, Amisha
Chandra, Subhash
Tiruneh, Yewulsew Kebede
Hassan, Hesham M.
Al-Emam, Ahmed
Sindi, Emad Rashad
Al-Dies, Al-Anood M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-81285-2
- URN
-
urn:nbn:de:101:1-2502192107245.901447673808
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rawat, Kalpana
- Tewari, Disha
- Bisht, Amisha
- Chandra, Subhash
- Tiruneh, Yewulsew Kebede
- Hassan, Hesham M.
- Al-Emam, Ahmed
- Sindi, Emad Rashad
- Al-Dies, Al-Anood M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Molecular mechanisms of sulforaphane in Alzheimer’s disease: insights from an in-silico study
The molecular mechanisms of Abyssinone-I protect against Alzheimer’s disease: an in-silico study
In-Silico discovery of 17alpha-hydroxywithanolide-D as potential neuroprotective allosteric modulator of NMDA receptor targeting Alzheimer’s disease
A Knowledge-based Integrative Modeling Approach for In-Silico Identification of Mechanistic Targets in Neurodegeneration with Focus on Alzheimer’s Disease
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
A knowledge-based integrative modeling approach for in-silico identification of mechanistic targets in neurodegeneration with focus on Alzheimers disease
In silico analysis of detrimental mutation in EPHB2 gene causing Alzheimer’s disease
Synthesis, in silico, and evaluation of AChE inhibitory activity of N-phthaloylphenylglycine derivatives as potential anti-Alzheimer’s agents
Improving in-silico normalization using read weights
Improving in-silico normalization using read weights
Systems patientomics: the virtual in-silico patient
In-silico endovascular repair of abdominal aortic aneurysms
Molecular mechanisms of sulforaphane in Alzheimer’s disease: insights from an in-silico study
The molecular mechanisms of Abyssinone-I protect against Alzheimer’s disease: an in-silico study
In-Silico discovery of 17alpha-hydroxywithanolide-D as potential neuroprotective allosteric modulator of NMDA receptor targeting Alzheimer’s disease
A Knowledge-based Integrative Modeling Approach for In-Silico Identification of Mechanistic Targets in Neurodegeneration with Focus on Alzheimer’s Disease
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
A knowledge-based integrative modeling approach for in-silico identification of mechanistic targets in neurodegeneration with focus on Alzheimers disease
In silico analysis of detrimental mutation in EPHB2 gene causing Alzheimer’s disease
Synthesis, in silico, and evaluation of AChE inhibitory activity of N-phthaloylphenylglycine derivatives as potential anti-Alzheimer’s agents
Improving in-silico normalization using read weights
Improving in-silico normalization using read weights
Systems patientomics: the virtual in-silico patient
In-silico endovascular repair of abdominal aortic aneurysms
Molecular mechanisms of sulforaphane in Alzheimer’s disease: insights from an in-silico study
The molecular mechanisms of Abyssinone-I protect against Alzheimer’s disease: an in-silico study
In-Silico discovery of 17alpha-hydroxywithanolide-D as potential neuroprotective allosteric modulator of NMDA receptor targeting Alzheimer’s disease
A Knowledge-based Integrative Modeling Approach for In-Silico Identification of Mechanistic Targets in Neurodegeneration with Focus on Alzheimer’s Disease
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
A knowledge-based integrative modeling approach for in-silico identification of mechanistic targets in neurodegeneration with focus on Alzheimers disease
In silico analysis of detrimental mutation in EPHB2 gene causing Alzheimer’s disease
Synthesis, in silico, and evaluation of AChE inhibitory activity of N-phthaloylphenylglycine derivatives as potential anti-Alzheimer’s agents
Improving in-silico normalization using read weights
Improving in-silico normalization using read weights
Systems patientomics: the virtual in-silico patient